Fate Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Fate Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 34% to $63,533,000. The net income raised on -$160,928,000 and profit margin reached -253%. Total operating expenses were $254,044,000.
Profit Margin
| 2014 | 0 | -25.88M | |
|---|---|---|---|
| 2015 | 2.43M | -29.99M | -1233.73% |
| 2016 | 4.40M | -33.46M | -760.15% |
| 2017 | 4.10M | -42.95M | -1046.08% |
| 2018 | 4.74M | -66.59M | -1405.02% |
| 2019 | 10.68M | -97.70M | -914.87% |
| 2020 | 31.43M | -170.3M | -541.77% |
| 2021 | 55.84M | -206.30M | -369.41% |
| 2022 | 96.3M | -255.05M | -264.86% |
| 2023 | 63.53M | -160.92M | -253.3% |
FATE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 63.53M | 96.3M | 55.84M | 31.43M | 10.68M | 4.74M | 4.10M | 4.40M | 2.43M | 0 |
Cost of revenue | 161.69M | 13.75M | 5.85M | 125.62M | 87.77M | 0 | 34.35M | 0 | 19.86M | 16.43M |
Gross profit | -98.16M | 82.54M | 49.99M | -94.18M | -77.09M | 4.74M | -30.25M | 4.40M | -17.43M | -16.43M |
Operating exp. | ||||||||||
Research and development | 172.59M | 320.45M | 215.51M | 125.62M | 87.77M | 56.02M | 34.35M | 26.45M | 19.86M | 16.43M |
Selling and marketing | -2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 254.04M | 404.68M | 272.84M | 159.51M | 111.40M | 71.83M | 46.23M | 36.36M | 30.21M | 24.90M |
Operating income | -190.51M | -308.38M | -216.99M | -128.08M | -100.72M | -67.09M | -42.12M | -31.96M | -27.78M | -24.90M |
Other income (expenses), net | 29.58M | 26.66M | 4.84M | -45.30M | 2.57M | 494K | -827K | -1.49M | -2.21M | -979K |
Income before tax | -160.92M | -281.72M | -212.15M | -173.38M | -98.14M | -66.59M | -42.95M | -33.46M | -29.99M | -25.88M |
Income tax expense | 0 | -26.66M | -5.85M | -3.08M | -441K | 2.19M | 297K | -743K | -677K | 53K |
Net income | -160.92M | -255.05M | -206.30M | -170.3M | -97.70M | -66.59M | -42.95M | -33.46M | -29.99M | -25.88M |
Earnings per share | ||||||||||
Basic EPS | -1.64 | -2.63 | -2.18 | -2.07 | -1.43 | -1.19 | -1.02 | -1.05 | -1.18 | -1.27 |
Diluted EPS | -1.64 | -2.63 | -2.18 | -2.07 | -1.43 | -1.19 | -1.02 | -1.05 | -1.18 | -1.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |